Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Viallet

Showing results (131-140 of 133) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 133 results.
Neurology|January 19, 2011
Mutations in the glucocerebrosidase gene confer a risk for Parkinson disease in North AfricaS Lesage, C Condroyer, N Hecham, et al.
Autoimmunity|January 1, 1990
Multiple sclerosis: cell-mediated immunity to human brain gangliosidesE Beraud, M M Golstein, F Viallet, et al.
Annals of Neurology|June 9, 1999
ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's diseaseO Rascol, O Blin, C Thalamas, et al.
Pageof 14

Showing results (131-140 of 133) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 133 results.
Neurology|January 19, 2011
Mutations in the glucocerebrosidase gene confer a risk for Parkinson disease in North AfricaS Lesage, C Condroyer, N Hecham, et al.
Autoimmunity|January 1, 1990
Multiple sclerosis: cell-mediated immunity to human brain gangliosidesE Beraud, M M Golstein, F Viallet, et al.
Annals of Neurology|June 9, 1999
ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's diseaseO Rascol, O Blin, C Thalamas, et al.
Pageof 14